[Myocardial scintigraphy using omega-I-123 heptadecanoic acid (Rossendorf) in patients with coronary disease].
Scintigraphy using labelled myocardial metabolism precursors makes possible a noninvasive qualitative--and increasingly also quantitative--evaluation of global and regional myocardium, both normally and insufficiently perfused, with normal and disturbed metabolism. Among the labelled precursors, free fatty acids appear as most important, especially the omega-123I-heptadecanoic acid. The experience with the use of this myocardial metabolism precursor in 23 examinations of 11 patients is described.
Lohr
E
E
I. Medizinische Klinik, Städtisches Krankenhaus im Friedrichshain, Berlin.
Mende
T
T
Steinbach
J
J
Hliscs
R
R
Anders
G
G
Franke
W G
WG
Beyer
G J
GJ
D003327:Coronary Disease / Q000000981:diagnostic imaging*; D005227:Fatty Acids; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D007457:Iodine Radioisotopes; D011877:Radionuclide Imaging
D005227:Fatty Acids; D007457:Iodine Radioisotopes; C013102:margaric acid
Die Myokardszintigraphie mit Omega-123I-Heptadekansäure (Rossendorf) bei Patienten mit koronarer Herzkrankheit.